Trade Vir Biotechnology Stock – Innovating Immunology to Fight Infectious Diseases

Vir Biotechnology Inc. (NASDAQ: VIR) is a clinical-stage immunology company focused on treating and preventing serious infectious diseases, including influenza, COVID-19, and hepatitis B. Using antibody and T-cell technologies, Vir aims to address unmet global health needs. Traded under the symbol VIR, it operates in the healthcare sector and appeals to biotech investors targeting infectious disease innovation.